U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia

Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine ...
Frontiers

Synergizing Experimental and Computational Methods for Structural Insights and Drug Discovery

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...
PharmiWeb

Nuclera Extends Series C Funding to $87M to Advance Antibody Engineering

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK GohThe funding will accelerate development of eProtein ...

Pearson and Deloitte announce new alliance to equip enterprises and government organizations with AI-powered learning and address the global skills gap

Pearson (FTSE: PSON.L) and Deloitte today announced an alliance to co-develop and deliver end-to-end talent, leadership, and ...